4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0000919574-21-000248
Director bought 2,500,000 shares at $2.60 ($6,500,000)
From the SEC's structured data for this filing
Trades in this filing
ARMISTICE CAPITAL, LLC · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-08 | Purchase : show line 1 in the form | +2,500,000 | $2.60 | $6,500,000 | 32,634,285 | D |
| 2021-01-08 | Purchase : show line 2 in the form | +0 | 32,634,285 | I | ||
| Open-market purchases · 2,500,000 sh · avg $2.60 · $6,500,000 | ||||||
Loading xslF345X03/ownership.xml…